Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Colla

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Nature|December 3, 2010
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cellsBoyi Gan, Jian Hu, Shan Jiang, et al.
Blood|October 24, 2002
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone diseaseNicola Giuliani, Simona Colla, Roberto Sala, et al.
Leukemia Research|March 13, 2016
Down-regulation of EZH2 expression in myelodysplastic syndromesMonica Cabrero, Yue Wei, Hui Yang, et al.
Blood|May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic targetIrma Airoldi, Claudia Cocco, Nicola Giuliani, et al.
European Journal of Haematology|April 3, 2004
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemiaSimona Colla, Gabriella Sammarelli, Monica Crugnola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testesNicola Giuliani, Cecilia Caramatti, Giovanni Roti, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
Leukemia|May 6, 2020
Activating somatic and germline TERT promoter variants in myeloid malignanciesValeria Nofrini, Caterina Matteucci, Fabrizia Pellanera, et al.
Experimental Hematology|December 8, 2009
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone diseaseKatia Todoerti, Gina Lisignoli, Paola Storti, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Nature|December 3, 2010
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cellsBoyi Gan, Jian Hu, Shan Jiang, et al.
Blood|October 24, 2002
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone diseaseNicola Giuliani, Simona Colla, Roberto Sala, et al.
Leukemia Research|March 13, 2016
Down-regulation of EZH2 expression in myelodysplastic syndromesMonica Cabrero, Yue Wei, Hui Yang, et al.
Blood|May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic targetIrma Airoldi, Claudia Cocco, Nicola Giuliani, et al.
European Journal of Haematology|April 3, 2004
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemiaSimona Colla, Gabriella Sammarelli, Monica Crugnola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testesNicola Giuliani, Cecilia Caramatti, Giovanni Roti, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Blood Advances|October 3, 2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in miceYue Wei, Hong Zheng, Naran Bao, et al.
Leukemia|May 6, 2020
Activating somatic and germline TERT promoter variants in myeloid malignanciesValeria Nofrini, Caterina Matteucci, Fabrizia Pellanera, et al.
Experimental Hematology|December 8, 2009
Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone diseaseKatia Todoerti, Gina Lisignoli, Paola Storti, et al.
Pageof 10